Service partnership.

Werum IT Solutions further extends its range of services as prime4services has been successfully certified as "PAS-X Endorsed Service Partner" for Europe. This qualifies prime4services to support pharma and biotech manufacturers during the implementation phase of Werum's PAS-X Manufacturing Execution System (MES) at production sites in the DACH region and Italy. prime4services is a service provider for independent consulting, engineering & IT services to optimize both quality and efficiency and to drive manufacturing excellence at the customer's site.

From left: Torsten Isenberg (Werum IT Solutions), Nicola Catania & Yasmine Peters (prime4services), Reiner Kühl (Werum IT Solutions)

"prime4services helps us further improve and expand support services for our European customers, in particular in Italy," Torsten Isenberg, Senior Director Services at Werum IT Solutions GmbH, is pleased to announce. "As PAS-X Endorsed Service Partner, prime4services provides independent consultancy services – typically at the customer's – and thus enhances Werum's service portfolio for our common customer base in a seamless way."

"By combining Werum's and prime4services's expertise, our customers will benefit from the long-term, complementary experience of our two companies. This partnership is a landmark and future-oriented decision for prime4services and Werum. We look forward to an exciting cooperation," says Yasmine Peters, Managing Director at prime4services.

PAS-X Endorsed Service Partners meet all requirements of Werum IT Solutions' PAS-X service partner program. The main objective of our program is to offer the same quality and competence of services to Werum customers all over the world – through reliable, experienced and certified partners. Our service partners need to have comprehensive PAS-X knowledge, participate at PAS-X trainings on a regular basis, possess experience in the regulated industries and use a quality management system. The certification has to be renewed on a regular basis.

@Werum #Pharma #MES